Bare Financial Services
BBIO icon

Bare Financial Services’s BridgeBio Pharma BBIO Stock Holding History

Bare Financial Services’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.25K Hold
19
– – ﹤0.01% 1381
2026
Q2 		$1.42K Buy
19
+8
+73% +$560 ﹤0.01% 1242
2026
Q1 		$817 Sell
11
-7
-39% -$507 ﹤0.01% 1338
2025
Q4 		$1.38K Buy
18
+7
+64% +$459 ﹤0.01% 1004
2025
Q3 		$571 Buy
+11
New +$536 ﹤0.01% 1213

Other funds holding BBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bare Financial Services's BBIO Position: Q3 2026 in Review

Bare Financial Services held its BridgeBio Pharma (BBIO) position steady in Q3 2026 at 19 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

Bare Financial Services first reported a position in BBIO in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.42K in Q2 2026. 202 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • Bare Financial Services held 19 shares of BridgeBio Pharma worth $1.25K as of Q3 2026.
  • Bare Financial Services left its BridgeBio Pharma share count unchanged in Q3 2026.
  • BridgeBio Pharma made up ﹤0.01% of Bare Financial Services's portfolio in Q3 2026, its #1381 holding.
  • Bare Financial Services first reported a position in BridgeBio Pharma in Q3 2025 and has held it in 5 quarters since.
  • Bare Financial Services's BridgeBio Pharma position peaked at $1.42K in Q2 2026.
  • 202 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on Bare Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.